Aligned to J9264: American Regent's Paclitaxel Protein-Bound Particles

Effective January 1, 2025:

American Regent's Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound) has been realigned to J9264

Based on October CMS publications, American Regent's NDC code 00517-4300-01 has been aligned with the HCPCS code J9264, effective January 1, 2025.

American Regent's paclitaxel product is now considered as a multi-source drug to be billed under J9264, the existing HCPCS code for Abraxane^®* for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound).

HCPCS Code	J9264
HCPCS Code Descriptor	Injection, paclitaxel protein-bound particles, 1 mg
NDC Number	00517-4300-01
Package Description	100 mg/vial; single-dose vial
HCPCS Billing Units in Package	100
WAC per HCPCS	$16.39

We respectfully request the update of all claims and reimbursement systems to include NDC: 00517-4300-01 aligned to the HCPCS: J9264.

Billing and Coding Guide

Full Prescribing Information

References:

“ASP Pricing Files.” CMS.gov. Accessed October 3, 2024. https://www.cms.gov/medicare/payment/part-b-drugs/asp-pricing-files.

*All trademarks are the property of their respective owners

November 2024 PP-PT-US-0047